SQZ Biotechnologies Company Reports Q1 Loss, Misses Revenue Estimates
SQZDelisted Stock | USD 0.10 0.04 28.57% |
Slightly above 62% of Sqz Biotechnologies' investor base is looking to short. The analysis of current outlook of investing in Sqz Biotechnologies Co suggests that many traders are alarmed regarding Sqz Biotechnologies' prospects. Sqz Biotechnologies' investing sentiment can be driven by a variety of factors including economic data, Sqz Biotechnologies' earnings reports, geopolitical events, and overall market trends.
Sqz |
SQZ Biotechnologies Company delivered earnings and revenue surprises of -11.11 percent and 100, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock
Read at finance.yahoo.com
Sqz Biotechnologies Fundamental Analysis
We analyze Sqz Biotechnologies' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sqz Biotechnologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sqz Biotechnologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Employees
Number Of Employees Comparative Analysis
Sqz Biotechnologies is currently under evaluation in number of employees category among its peers. Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Sqz Biotechnologies Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sqz Biotechnologies stock to make a market-neutral strategy. Peer analysis of Sqz Biotechnologies could also be used in its relative valuation, which is a method of valuing Sqz Biotechnologies by comparing valuation metrics with similar companies.
Peers
Sqz Biotechnologies Related Equities
ANTX | AN2 Therapeutics | 21.90 | ||||
PCSA | Processa Pharmaceuticals | 18.37 | ||||
MNPR | Monopar Therapeutics | 8.84 | ||||
IKT | Inhibikase Therapeutics | 6.96 | ||||
LIPO | Lipella Pharmaceuticals | 5.42 | ||||
QNRX | Quoin Pharmaceuticals | 1.69 | ||||
HOWL | Werewolf Therapeutics | 1.52 | ||||
PMVP | Pmv Pharmaceuticals | 1.25 | ||||
KZR | Kezar Life | 0.95 | ||||
SNTI | Senti Biosciences | 0.93 | ||||
FENC | Fennec Pharmaceuticals | 0.83 | ||||
ANEB | Anebulo Pharmaceuticals | 0.70 | ||||
NUVB | Nuvation Bio | 0.35 | ||||
SABS | SAB Biotherapeutics | 1.02 | ||||
THRD | Third Harmonic | 2.67 | ||||
CADL | Candel Therapeutics | 4.85 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Consideration for investing in Sqz Stock
If you are still planning to invest in Sqz Biotechnologies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Sqz Biotechnologies' history and understand the potential risks before investing.
Global Correlations Find global opportunities by holding instruments from different markets | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |